• 1. Pyrimidines. Part XXIII. Synthesis of pyrimido[4,5-b][1,4]oxazines by reaction of 4,5-diaminopyrimidine derivatives with α-halogeno-ketones
  Jean Mirza,Wolfgang Pfleiderer,A. D. Brewer,Alexander Stuart,H. C. S. Wood J. Chem. Soc. C 1970 437
• 2. Effect of substituents of alloxazine derivatives on the selectivity and affinity for adenine in AP-site-containing DNA duplexes
  Burki Rajendar,Arivazhagan Rajendran,Zhiqiang Ye,Eriko Kanai,Yusuke Sato,Seiichi Nishizawa,Marek Sikorski,Norio Teramae Org. Biomol. Chem. 2010 8 4949
• 3. 6,7-Dimethyllumazine as a potential ligand for selective recognition of adenine opposite an abasic site in DNA duplexes
  Zhiqiang Ye,Burki Rajendar,Dai Qing,Seiichi Nishizawa,Norio Teramae Chem. Commun. 2008 6588
• 4. A quantitative structure–property relationship (QSPR) study of singlet oxygen generation by pteridines
  Andrey A. Buglak,Taisiya A. Telegina,Mikhail S. Kritsky Photochem. Photobiol. Sci. 2016 15 801
• 5. Pterins. Part 2. Stereochemistry of catalytic reduction of 6-methyl- and 6,7-dimethyl-pterin and of 2,4-diamino-6-methylpteridine
  Wilfred L. F. Armarego,Henning Schou J. Chem. Soc. Perkin Trans. 1 1977 2529

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pteridines and derivatives Pterins and derivatives

Introduction to 6,7-Dimethylpterin (CAS No: 611-55-2)

6,7-Dimethylpterin, identified by the Chemical Abstracts Service Number (CAS No) 611-55-2, is a significant compound in the field of biochemical and pharmaceutical research. This heterocyclic organic molecule, belonging to the pterin family, has garnered considerable attention due to its structural similarity to naturally occurring pterins such as tetrahydrobiopterin (BH4) and its potential applications in medicinal chemistry and enzyme regulation.

The molecular structure of 6,7-Dimethylpterin consists of a pyrimidine ring fused with a pyranone moiety, with two methyl groups substituting at the 6th and 7th positions of the pyrimidine ring. This unique arrangement imparts distinct electronic and steric properties, making it a valuable scaffold for drug design and biochemical studies. The compound's ability to interact with various enzymes and biological pathways has positioned it as a subject of intense investigation in synthetic chemistry and pharmacology.

In recent years, 6,7-Dimethylpterin has been explored for its potential role in modulating enzymatic activities, particularly those involving flavoproteins and oxidoreductases. Research has highlighted its interaction with enzymes such as xanthine oxidase and dihydrofolate reductase (DHFR), which are crucial in metabolic pathways related to nucleotide biosynthesis. The structural analogs of natural pterins have been studied for their ability to influence enzyme kinetics and substrate specificity, offering insights into the development of novel therapeutic agents.

One of the most compelling areas of research involving 6,7-Dimethylpterin is its application in addressing metabolic disorders. Studies have demonstrated that modifications in the pterin ring system can lead to compounds with enhanced binding affinity or altered functional properties. For instance, derivatives of 6,7-Dimethylpterin have been investigated for their potential in treating conditions associated with enzyme deficiencies or dysregulation. These findings underscore the importance of 6,7-Dimethylpterin as a chemical probe for understanding disease mechanisms and developing targeted therapies.

The synthesis of 6,7-Dimethylpterin has been optimized through various methodologies, including condensation reactions and cyclization processes. Advances in synthetic chemistry have enabled the production of high-purity samples suitable for biochemical assays and pharmacological studies. The availability of well-characterized 6,7-Dimethylpterin has facilitated its use in high-throughput screening programs aimed at identifying novel bioactive compounds. Such efforts have led to the discovery of several promising candidates for further development into therapeutic agents.

From a computational chemistry perspective, 6,7-Dimethylpterin has been subjected to detailed molecular modeling studies to elucidate its interactions with biological targets. Quantum mechanical calculations have provided insights into the electronic structure and reactivity of the molecule, aiding in the rational design of derivatives with improved pharmacological properties. These computational approaches complement experimental investigations by predicting binding affinities and metabolic stability.

The role of 6,7-Dimethylpterin in redox biology has also been a focus of recent research. Pterins are known to participate in electron transfer processes within cellular metabolism, and modifications to their structure can alter their redox properties. Investigations into 6,7-Dimethylpterin have revealed its potential as an electron shuttle molecule in enzymatic reactions, contributing to our understanding of oxidative stress mechanisms and antioxidant defense systems.

In conclusion, 6,7-Dimethylpterin (CAS No: 611-55-2) represents a fascinating compound with diverse applications in biochemical research and pharmaceutical development. Its structural features and interactions with biological systems make it a valuable tool for studying enzyme function, metabolic pathways, and disease mechanisms. As research continues to uncover new aspects of this molecule's properties and potential applications, it is likely that 6,7-Dimethylpterin will remain at the forefront of investigations in medicinal chemistry and drug discovery.

• 916248-94-7(2-Pteridinamine, 6,7-dimethyl-4-(pentyloxy)-)
• 2277-47-6(2-Pteridinamine, 4-methoxy-6,7-dimethyl-)
• 93675-17-3(4-Pteridinol, 2-amino-)
• 13045-87-9
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)